Punctuated evolution of canonical genomic aberrations in uveal melanoma

Cancer is thought to arise through the accumulation of genomic aberrations evolving under Darwinian selection. However, it remains unclear when the aberrations associated with metastasis emerge during tumor evolution. Uveal melanoma (UM) is the most common primary eye cancer and frequently leads to metastatic death, which is strongly linked to BAP1 mutations. Accordingly, UM is ideally suited for studying the clonal evolution of metastatic competence. Here we analyze sequencing data from 151 primary UM samples using a customized bioinformatic pipeline, to improve detection of BAP1 mutations and infer the clonal relationships among genomic aberrations. Strikingly, we find BAP1 mutations and other canonical genomic aberrations usually arise in an early punctuated burst, followed by neutral evolution extending to the time of clinical detection. This implies that the metastatic proclivity of UM is “set in stone” early in tumor evolution and may explain why advances in primary treatment have not improved survival. Uveal melanoma (UM), the most common primary eye cancer, is strongly linked to mutations in the tumor suppressor BAP1. Here, the authors analyze 151 primary UM samples to find that BAP1 and other canonical genomic aberrations arise in an early punctuated burst followed by neutral tumor evolution.

• Publication year

  2018

• Venue

  Nature Communications

• Publication date

  2018-01-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41467-017-02428-wPMID 29317634PMCID 5760704
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sequence Analysis

  2020cited by this paper
• Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating splicing

  2017cited by this paper
• Identification of neutral tumor evolution across cancer types

  2016cited by this paper
• Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas

  2016cited by this paper
• Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma

  2016cited by this paper
• Punctuated Copy Number Evolution and Clonal Stasis in Triple-Negative Breast Cancer

  2016cited by this paper
• Complex heatmaps reveal patterns and correlations in multidimensional genomic data

  2016cited by this paper
• CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing

  2016cited by this paper
• Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.

  2016cited by this paper
• Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing.

  2016cited by this paper
• A Big Bang model of human colorectal tumor growth

  2015cited by this paper
• Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies.

  2015cited by this paper
• The Genetic Evolution of Melanoma from Precursor Lesions.

  2015cited by this paper
• The Evolutionary History of Lethal Metastatic Prostate Cancer

  2015cited by this paper
• A Simple Model-Based Approach to Inferring and Visualizing Cancer Mutation Signatures

  2015cited by this paper
• Analysis of the Genetic Phylogeny of Multifocal Prostate Cancer Identifies Multiple Independent Clonal Expansions in Neoplastic and Morphologically Normal Prostate Tissue

  2015cited by this paper
• Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination

  2015cited by this paper
• SRSF2 Is Essential for Hematopoiesis, and Its Myelodysplastic Syndrome-Related Mutations Dysregulate Alternative Pre-mRNA Splicing

  2015cited by this paper
• Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4

  2015cited by this paper
• Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets

  2015cited by this paper
• ABRA: improved coding indel detection via assembly-based realignment

  2014cited by this paper
• RADIA: RNA and DNA Integrated Analysis for Somatic Mutation Detection

  2014cited by this paper
• Modeling DNA methylation dynamics with approaches from phylogenetics

  2014cited by this paper
• ChAMP: 450k Chip Analysis Methylation Pipeline

  2014cited by this paper
• A molecular revolution in uveal melanoma: implications for patient care and targeted therapy.

  2014cited by this paper
• A day in the life of the spliceosome

  2014cited by this paper
• Integrated RNA and DNA sequencing improves mutation detection in low purity tumors

  2014cited by this paper
• Comparison of somatic mutation calling methods in amplicon and whole exome sequence data

  2014cited by this paper
• CGAT: computational genomics analysis toolkit

  2014cited by this paper
• TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data

  2014cited by this paper
• Signatures of mutational processes in human cancer

  2013cited by this paper
• Using VarScan 2 for Germline Variant Calling and Somatic Mutation Detection

  2013cited by this paper
• Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

  2013cited by this paper
• SF3B1 mutations are associated with alternative splicing in uveal melanoma.

  2013cited by this paper
• Cancer Genome Landscapes

  2013cited by this paper
• The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal Melanoma

  2013cited by this paper
• Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma

  2013cited by this paper
• Count-based differential expression analysis of RNA sequencing data using R and Bioconductor

  2013cited by this paper
• Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3

  2013cited by this paper
• Predicting the functional consequences of cancer-associated amino acid substitutions

  2013cited by this paper
• STAR: ultrafast universal RNA-seq aligner

  2013cited by this paper
• Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

  2013cited by this paper
• The genetics of uveal melanoma: an emerging framework for targeted therapy

  2012cited by this paper
• Dynamic protein-protein interaction wiring of the human spliceosome.

  2012cited by this paper
• The Life History of 21 Breast Cancers

  2012cited by this paper
• Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma.

  2012cited by this paper
• Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.

  2012cited by this paper
• VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.

  2012cited by this paper
• Collaborative Ocular Oncology Group Report No. 1: Prospective Validation of a Multi-Gene Prognostic Assay in Uveal Melanoma

  2012cited by this paper
• Germline mutations in BAP1 predispose to melanocytic tumors

  2011cited by this paper
• Frequent pathway mutations of splicing machinery in myelodysplasia

  2011cited by this paper
• Tumour evolution inferred by single-cell sequencing

  2011cited by this paper
• A method and server for predicting damaging missense mutations

  2010cited by this paper
• Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas

  2010cited by this paper
• Allele-specific copy number analysis of tumors

  2010cited by this paper
• Mutations in GNA11 in uveal melanoma.

  2010cited by this paper
• ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

  2010cited by this paper
• Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma

  2009cited by this paper
• Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases.

  2009cited by this paper
• Oncogenic mutations in GNAQ occur early in uveal melanoma.

  2008cited by this paper
• Frequent somatic mutations of GNAQ in uveal melanoma and blue nevi

  2008cited by this paper
• Dissecting karyotypic patterns in malignant melanomas: Temporal clustering of losses and gains in melanoma karyotypic evolution

  2004cited by this paper
• Gene Expression Profiling in Uveal Melanoma Reveals Two Molecular Classes and Predicts Metastatic Death

  2004cited by this paper
• APE: Analyses of Phylogenetics and Evolution in R language

  2004cited by this paper
• Survival rates with uveal melanoma in the United States: 1973-1997.

  2003cited by this paper
• Fast and Accurate Phylogeny Reconstruction Algorithms Based on the Minimum-Evolution Principle

  2002cited by this paper
• Possible cause of G-C-->C-G transversion mutation by guanine oxidation product, imidazolone.

  2001cited by this paper
• Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment.

  2000cited by this paper
• BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression

  1998cited by this paper

• Research progress on glycolytic reprogramming in ophthalmic diseases

  2026cites this paper
• Recent advances in the molecular genetic mechanisms and immune microenvironment of uveal melanoma.

  2026cites this paper
• Independent validation of time to treatment as a prognostic factor in uveal melanoma

  2026cites this paper
• Tracking ongoing chromosomal instability using single-cell whole-genome sequencing

  2025cites this paper
• Identification of two distinct uveal melanoma subtypes based on the immune cell infiltration of the primary tumour

  2025cites this paper
• Knockdown of PR-DUB subunit calypso in the developing Drosophila eye and wing results in mis-patterned tissues with altered size and shape

  2025cites this paper
• Swept-Source OCT Angiography Features of Melanotic Choroidal Tumors: An Analysis of 102 Consecutive Cases

  2025cites this paper
• Metastatic potential of small posterior uveal melanomas

  2025influential citation
• Spontaneous Mesotheliomas in Germline Bap1 Heterozygous Mice from Different Genetic Backgrounds

  2025cites this paper
• View Micronuclei in the Extent of Evolution: New Insight Into an Old Issue

  2025cites this paper
• Uveal Melanoma UK national guidelines: 2023 update.

  2025cites this paper
• Molecular determinants of survival in metastatic uveal melanoma: The impact of SF3B1 mutations.

  2025cites this paper
• Twelve reasons delays in uveal melanoma treatment might affect prognosis

  2025cites this paper
• Early Genetic Evolution of Driver Mutations in Uveal Melanoma

  2025cites this paper
• Higher AJCC stage at primary tumor diagnosis may predict shorter survival in metastatic uveal melanoma

  2025cites this paper
• Co-occurrence of EIF1AX, SF3B1, or BAP1 variants in uveal melanomas: A case series and review

  2025cites this paper
• Identification of diagnostic and prognostic genetic alterations in uveal melanoma using RNA sequencing

  2025cites this paper
• Punctuational evolution is pervasive in distal site metastatic colonization

  2025cites this paper
• Current findings of genetic alterations and associated targeted therapies of conjunctival melanocytic neoplasms

  2025cites this paper
• Early genetic evolution of driver mutations in uveal melanoma

  2025influential citation
• Electrochemical sensors and bioinformatics used for analyzing Warburg effect-associated metastasis and prognostic biomarkers in uveal melanoma

  2025cites this paper
• Pathogenic Germline Variants in Uveal Melanoma Driver and BAP1‐Associated Genes in Finnish Patients with Uveal Melanoma

  2024cites this paper
• Survival Benefit of Primary Tumor Treatment in Uveal Melanoma: A Re-Analysis of the Collaborative Ocular Melanoma Study (COMS) and Natural History Study (NHS) Cohorts

  2024cites this paper
• Identification of targetable epigenetic vulnerabilities for uveal melanoma

  2024cites this paper
• Characterization of somatic mutations in sporadic uveal melanoma and uveal melanoma in patients with germline BAP1 pathogenic variants

  2024cites this paper
• Malignant melanoma complicated with cataract and secondary glaucoma: A case report

  2024cites this paper
• Uveal Melanoma: Comprehensive Review of Its Pathophysiology, Diagnosis, Treatment, and Future Perspectives

  2024cites this paper
• 15-Gene Expression Profile and PRAME as Integrated Prognostic Test for Uveal Melanoma: First Report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1)

  2024cites this paper
• Oncotree2vec — a method for embedding and clustering of tumor mutation trees

  2024cites this paper
• Single cell RNA-sequencing in uveal melanoma: advances in heterogeneity, tumor microenvironment and immunotherapy

  2024cites this paper
• Do Short Delays in Treatment Affect Uveal Melanoma Prognosis?

  2024cites this paper
• Recent Advances in Molecular and Genetic Research on Uveal Melanoma

  2024cites this paper
• Choroidal Nevi in Children: Size, Growth, and Topographic Distribution.

  2024cites this paper
• [Circumscribed choroidal hemangioma and non-pigmented choroidal melanoma: clinical, instrumental and molecular genetic features].

  2024cites this paper
• Heterogeneity and molecular landscape of melanoma: implications for targeted therapy

  2024cites this paper
• Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility

  2024cites this paper
• Trends in the Clinical Presentation of Uveal Melanoma During the COVID-19 Pandemic.

  2024cites this paper
• Expression of GNAQ, BAP1, SF3B1, and EIF1AX Proteins in the Aqueous Humor of Eyes Affected by Uveal Melanoma.

  2024cites this paper
• Interdependence of Molecular Lesions That Drive Uveal Melanoma Metastasis

  2023influential citation
• Genetic Aspects of Conjunctival Melanoma: A Review

  2023cites this paper
• Activation of NFAT by HGF and IGF-1 via ARF6 and its effector ASAP1 promotes uveal melanoma metastasis

  2023cites this paper
• PHF5A as a new OncoTarget and therapeutic prospects

  2023cites this paper
• Uveal Melanoma in African Americans: Diagnostic Challenges.

  2023cites this paper
• Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans-differentiation, and drug resistance.

  2023cites this paper
• Cuproptosis and its application in different cancers: an overview

  2023cites this paper
• Cerivastatin Synergizes with Trametinib and Enhances Its Efficacy in the Therapy of Uveal Melanoma

  2023cites this paper
• Spatiotemporal view of malignant histogenesis and macroevolution via formation of polyploid giant cancer cells

  2023cites this paper
• Delays Between Uveal Melanoma Diagnosis and Treatment Increase the Risk of Metastatic Death.

  2023cites this paper
• oncotree2vec – A method for embedding and clustering of tumor phylogenetic trees

  2023cites this paper
• LKB1‐SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition

  2023cites this paper
• The Long-term Prognosis of Patients with Untreated Primary Uveal Melanoma: A Systematic Review and Meta-Analysis.

  2022cites this paper
• New targeted and epigenetic therapeutic strategies for the treatment of uveal melanoma.

  2022cites this paper
• Statistical Mechanical theory for spatio-temporal evolution of Intra-tumor heterogeneity in cancers: Analysis of Multiregion sequencing data

  2022cites this paper
• Chemosaturation with percutaneous hepatic perfusion of melphalan for metastatic uveal melanoma

  2022cites this paper
• Unusual Histology in Mesothelioma: A Report of Two Cases with a Brief Review

  2022cites this paper
• From Samples to Germline and Somatic Sequence Variation: A Focus on Next-Generation Sequencing in Melanoma Research

  2022cites this paper
• Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases

  2022cites this paper
• Pyruvate dehydrogenase inactivation causes glycolytic phenotype in BAP1 mutant uveal melanoma

  2022cites this paper
• Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors

  2022cites this paper
• Identification of a prognostic model using cuproptosis-related genes in uveal melanoma

  2022cites this paper
• Loss of chromosome Y in primary tumors

  2022cites this paper
• Analysis of uveal melanomas and paired constitutional DNA for exclusion of a BAP1-tumor predisposition syndrome

  2022cites this paper
• A prognostic classification system for uveal melanoma based on a combination of patient age and sex, the American Joint Committee on Cancer and the Cancer Genome Atlas models

  2022cites this paper
• Trends in Uveal Melanoma Presentation and Survival During Five Decades: A Nationwide Survey of 3898 Swedish Patients

  2022cites this paper
• A Novel and Easy-to-Promote Prognostic Model for Patients With Uveal Melanoma

  2022cites this paper
• The Genetic Evolution of Metastasis.

  2022cites this paper
• Reconstructing single-cell karyotype alterations in colorectal cancer identifies punctuated and gradual diversification patterns

  2021cites this paper
• Biology of Melanoma.

  2021cites this paper
• Applying Single-Cell Technology in Uveal Melanomas: Current Trends and Perspectives for Improving Uveal Melanoma Metastasis Surveillance and Tumor Profiling

  2021cites this paper
• Role of somatic mutations and chromosomal aberrations in the prognosis of uveal melanoma in a Spanish patient cohort

  2021cites this paper
• Genetic drivers of non‐cutaneous melanomas: Challenges and opportunities in a heterogeneous landscape

  2021cites this paper
• Roles and mechanisms of BAP1 deubiquitinase in tumor suppression

  2021cites this paper
• Microsimulation Model for Evaluating the Cost-Effectiveness of Surveillance in BAP1 Pathogenic Variant Carriers.

  2021cites this paper
• Genetic and non-genetic clonal diversity in cancer evolution

  2021cites this paper
• Posterior uveal melanoma incidence and survival by AJCC tumour size in a 70‐year nationwide cohort

  2021cites this paper
• Therapeutic Escape in Gαq-mutant Uveal Melanoma: It's a FAK

  2021cites this paper
• Circulating Tumor DNA Reflects Uveal Melanoma Responses to Protein Kinase C Inhibition

  2021cites this paper
• Translation of single-cell transcriptomic analysis of uveal melanomas to clinical oncology.

  2021cites this paper
• Small High-Risk Uveal Melanomas Have a Lower Mortality Rate

  2021cites this paper
• Orthotopic Human Metastatic Uveal Melanoma Xenograft Mouse Models: Applications for Understanding the Pathophysiology and Therapeutic Management of Metastatic Uveal Melanoma

  2021cites this paper
• Melanoma genomics: a state‐of‐the‐art review of practical clinical applications *

  2021cites this paper
• Multiple genetically distinct uveal melanomas arise in the same eye of two patients with melanosis oculiUnilateral multifocal uveal melanoma in melanosis oculi.

  2021cites this paper
• What’s in a Name? Large Choroidal Nevus, Small Choroidal Melanoma, or Indeterminate Melanocytic Tumor

  2021cites this paper
• Melanoma-derived induced pluripotent stem cells

  2021cites this paper
• The Genetics of Uveal Melanoma: Overview and Clinical Relevance Genetik der Aderhautmelanome: Übersicht und klinische Relevanz

  2021cites this paper
• Multiregional genetic evolution of metastatic uveal melanoma

  2021cites this paper
• Unraveling the Wide Spectrum of Melanoma Biomarkers

  2021cites this paper
• Identification and Evaluation of Autoantibody to a Novel Tumor-Associated Antigen GNA11 as a Biomarker in Esophageal Squamous Cell Carcinoma

  2021cites this paper
• RNA-binding proteins of COSMIC importance in cancer.

  2021cites this paper
• Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes

  2021cites this paper
• Molecular Basis of Uveal Melanoma and Emerging Therapeutic Targets

  2021cites this paper
• Uveal Melanoma: Genetics and Clinical Prognostication

  2021cites this paper
• Gene Expression Profiling in the Management of Uveal Melanoma

  2021cites this paper
• Presumed incipient choroidal melanoma: proposed diagnostic criteria and management

  2021cites this paper
• Potential of miRNA-Based Nanotherapeutics for Uveal Melanoma

  2021cites this paper
• Skin Cancer: Molecular Biomarker for Diagnosis, Prognosis, Prevention, and Targeted Therapy

  2021cites this paper
• No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter

  2021cites this paper
• PTK2 Promotes Uveal Melanoma Metastasis by Activating Epithelial-to-Mesenchymal Transition

  2021cites this paper
• Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma

  2021cites this paper
• Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma.

  2021cites this paper